Rui Lopes is a self-driven and skilled researcher with extensive professional experience in biomedical research. Currently a Principal Scientist at Roche, they apply CRISPR-Cas9 and next-generation sequencing technologies to identify new therapeutic targets in cancer at Novartis Oncology. Rui previously served as a PhD Researcher at The Netherlands Cancer Institute and as a Postdoctoral Researcher at Novartis Institutes for BioMedical Research. Their career in drug development and clinical research is focused on bringing innovative medicines to the clinic.
This person is not in the org chart
This person is not in any teams
This person is not in any offices